Skip to main content
CHIMERIC THERAPEUTICS LIMITED logo

CHIMERIC THERAPEUTICS LIMITED — Investor Relations & Filings

Ticker · CHM ISIN · AU0000121576 ASX Professional, scientific and technical activities
Open in API
Filings indexed 518 across all filing types
Latest filing 2026-05-19 Share Issue/Capital Cha…
Country AU Australia
Listing ASX CHM

About CHIMERIC THERAPEUTICS LIMITED

https://www.chimerictherapeutics.com

Chimeric Therapeutics Limited is a clinical-stage cell therapy company focused on the development and commercialization of innovative oncology treatments. The company specializes in chimeric antigen receptor (CAR) T-cell and natural killer (NK) cell therapies designed to target solid tumors and hematologic malignancies. Its lead candidate, CHM 1101 (CLTX CAR T), is a first-in-class therapy utilizing chlorotoxin to target glioblastoma. Additionally, the company is developing CHM 2101, a CDH17-targeted CAR T-cell therapy for gastrointestinal cancers, and the CORE-NK platform, which provides a foundation for off-the-shelf NK cell therapies. By leveraging advanced cellular engineering, Chimeric Therapeutics aims to address significant unmet needs in cancer care through precision medicine and novel therapeutic platforms.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - CHM 6 pages 18.4KB
Share Issue/Capital Change Classification · 95% confidence The document is an ASX Appendix 2A “Application for quotation of securities” announcing the conversion of convertible notes into ordinary shares and applying to list those new securities. This is a share issuance and capital change announcement rather than a financial report or general regulatory filing. Therefore it falls under Share Issue/Capital Change (SHA).
2026-05-19 English
Application for quotation of securities - CHM 6 pages 18.4KB
Share Issue/Capital Change Classification · 95% confidence The document is an ASX Appendix 2A application for quotation of securities, detailing the issue of 512,820 new fully paid ordinary shares upon conversion of convertible notes and providing updated issued capital figures. This is an announcement of a capital change (new share issue), which fits under our 'Share Issue/Capital Change' category.
2026-05-11 English
Application for quotation of securities - CHM 6 pages 18.4KB
Share Issue/Capital Change Classification · 92% confidence The document is an ASX Appendix 2A “Application for quotation of securities,” detailing the number of shares issued, issue dates, and changes to issued capital following the new listing. This is an announcement of a new share issue/capital change rather than a financial report or AGM material. It fits the “Share Issue/Capital Change” category (Code: SHA).
2026-05-11 English
Notice under section 708A 1
Share Issue/Capital Change Classification · 88% confidence The document is an ASX announcement titled “Notice Under Section 708A(5)(e) of the Corporations Act 2001” detailing a new issue of ordinary shares (class, ASX code, date of issue, number issued) and compliance statements regarding the issuance. This is a direct announcement of a share issuance event and fits the category for Share Issue/Capital Change (SHA).
2026-05-11 English
Proposed issue of securities - CHM 5 pages 17.2KB
Regulatory Filings
2026-05-07 English
Change in substantial holding 2 pages 397.5KB
Regulatory Filings
2026-05-04 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.